Atlas Trials

Sunitinib® in Patients With Recurrent Ovarian Clear Cell Carcinoma

Clinical trial NCT01824615 · COMPLETED

Trial details

NCT number
NCT01824615
Sponsor
Cathay General Hospital
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Ovarian CancerAdverse Effects
Start date
2013-01-01
Primary completion
2016-01-01
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.